| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |